Impact on Diastolic Function, Remodeling, and Hemodynamics The present study demonstrates a substantial improvement of diastolic function, which was already highly significant after 4 weeks of Empa alongside a reduced LV end-diastolic pressure and reduced myocardial stiffness after 8 weeks of treatment.
← all excerpts
Empagliflozin Improves Diastolic Function in HFpEF by Restabilizing the Mitochondrial Respiratory Chain.
1
—
—